
Sign up to save your podcasts
Or


In today’s episode of My Verbal Journal, we’re diving into the GLP-1 era : Ozempic, tirzepatide, and the cultural explosion surrounding them.
From type 2 diabetes treatment to 20% weight loss trials, these medications have completely changed the obesity conversation. But with that shift has come celebrity/influencer culture, telehealth prescriptions, college girls using it cosmetically, and a lot of misinformation.
In this episode, I break down:
We also talk about the bigger picture: how obesity is now recognized as a chronic disease, how media shaped the “Ozempic trend,” and why the smallest body possible should never be the goal.
Personal IG: @macileejones
Podcast IG: @myverbaljournal.letschat
By Maci JonesIn today’s episode of My Verbal Journal, we’re diving into the GLP-1 era : Ozempic, tirzepatide, and the cultural explosion surrounding them.
From type 2 diabetes treatment to 20% weight loss trials, these medications have completely changed the obesity conversation. But with that shift has come celebrity/influencer culture, telehealth prescriptions, college girls using it cosmetically, and a lot of misinformation.
In this episode, I break down:
We also talk about the bigger picture: how obesity is now recognized as a chronic disease, how media shaped the “Ozempic trend,” and why the smallest body possible should never be the goal.
Personal IG: @macileejones
Podcast IG: @myverbaljournal.letschat